Plasma p53 protein and anti-p53 antibody expression in vinyl chloride monomer workers in Taiwan

Journal of Occupational and Environmental Medicine

Volumn 41, Issue 6, 1999, Pages 521-526

  Luo, Jiin Chyuan John ^a,b   Liu, Hsien Ta ^a   Cheng, Tsun Jen ^c   Du, Chung Li ^c   Wang, Jung Der ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PROTEIN P53; PROTEIN P53 ANTIBODY; UNCLASSIFIED DRUG; VINYL CHLORIDE;

ADULT; ALCOHOL CONSUMPTION; ANGIOSARCOMA; ARTICLE; CHEMICAL INDUSTRY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; GENE OVEREXPRESSION; GENOTOXICITY; HEPATITIS B; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOKING HABIT; TAIWAN;

ADULT; AGED; ANTIBODIES; BIOLOGICAL MARKERS; CARCINOGENS; COHORT STUDIES; HEMANGIOSARCOMA; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; TAIWAN; TUMOR SUPPRESSOR PROTEIN P53; VINYL CHLORIDE;

EID: 0033003337     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-199906000-00020     Document Type: Article

References (29)

1. Schulte PA, Perera FP. Molecular Epidemiology: Principles and Practice. San Diego, CA: Academic Press; 1993.
2. Balmain A, Brown K. Oncogene activation in chemical carcinogenesis. Adv Cancer Res. 1988;51:147-182.
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science. 1991;253:49-53.
4. Hollstein M, Rice K, Greenblatt MS, Sousst T, Fuchs R, Sorlie T. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 1994;22:3551-3555.
5. Volgelstein B, Kinzler KW. P53 function and dysfunction. Cell. 1992;70:523-526.
6. Prives C, Manfredi JJ. The p53 tumor suppressor protein: meeting review. Genes Dev. 1993;7:529-534.
7. Lane DP. On the expression of the p53 protein in human cancer. Mol Biol Rep. 1994;19:23-29.
8. Smith S, Luo JCJ, Brandt-Rauf P. Mutant p53 protein as a biomarker of chemical carcinogenesis in human. J Occup Environ Med. 1996;38:743.
9. Agency for Toxic Substances and Disease Registry. Toxicology Profile for Vinyl Chloride: TP-92/20. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 1993.
10. Barbin A, Bartsch M. Mutagenic and promutagenic properties of DNA adducts formed by vinyl chloride metabolites. In: Singer B, Bartsch H, eds. The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis. Lyon, France: IARC; 1986:345-358.
11. Cheng KC, Preston BD, Cahill DS, Dosanjh MK, Singer B, Loeb LA. The vinyl chloride DNA derivative N2, 3-ethenoquanine produces G→A transitions in Escherichia coli. Proc Natl Acad Sci USA. 1991;88:9974-9978.
12. Hollstein M, Marion MJ, Lehman T, et al. P53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis. 1994; 15:1-3.
13. Smith SJ, Li Y, Whitley R, Brandt-Rauf PW. Molecular epidemiology of p53 protein mutations in workers exposed to vinyl chloride. Am J Epidemiol. 1998; 147:302-308.
14. Li Y, Asheron M, Marion MJ, Brandt-Rauf PW. Mutant oncoprotein biomarkers in chemical carcinogenesis. In: Meadelsohn ML, Mohr LC, Peters JP, eds. Biomarkers: Medical And Workplace Applications. Washington, DC: Joseph Henry Press; 1998:345-353.
15. Trivers GE, Cawley HL, Hollstein M, Marion MJ, Harris C. Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J Natl Cancer Inst. 1995;87:1400-1407.
16. Du CL, Wang JD. Increased morbidity odds ratio of primary liver cancer and cirrhosis of the liver among vinyl chloride monomer workers. Occup Environ Med. 1998;55:528-532.
17. Du CL, Chan CC, Wang JD. Comparison of personal and area sampling strategies in assessing workers' exposure to vinyl chloride monomer. Bull Environ Contam Toxicol. 1996;56:534-542.
18. SAS Institute. SAS Statistical Package, Version 6. Cary, NC: SAS Institute, Inc.; 1990.
19. Database III plus. Torrance, CA: AshtonTate; 1986.
20. Luo JC, Liu HT, Cheng TJ, Du CL, Wang JD. Plasma Asp13-Ki-ras oncoprotein expression in vinyl chloride monomer workers in Taiwan. J Occup Environ Med. 1998;40:1053-1058.
21. Marion MJ, DeVivo I, Smith S, Luo JC, Brandt-Rauf PW. The molecular epidemiology of occupational carcinogenesis in vinyl chloride workers. Int Arch Occup Environ Health. 1996;68:394-398.
22. Luo JC, Zehab R, Anttila S, et al. Detection of serum p53 protein in lung cancer patients. J Occup Med. 1994;36:155-160.
23. Hefner RE, Watanabe PG, Gehring PJ. Preliminary studies of the fate of inhaled vinyl chloride monomer in rats. Ann NY Acad Sci. 1975;246:135-148.
24. Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome p-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991;4:168-179.
25. Radike MJ, Stemmer KL, Binghem E. Effect of ethanol on vinyl chloride carcinogenesis. Environ Health Perspect. 1981;41:59-62.
26. Kondo K, Tsuzuki H, Sasa M. A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients. J Surg Oncol. 1996;41:59-62.
27. Partanen R, Koskinen H, Oksa P. Serum oncoproteins in asbestosis patients. Clin Chem. 1995;41:1844-1847.
28. Hemminki K, Partnanen R, Koskinen H. The molecular epidemiology of oncoproteins: serum p53 protein in patients with asbestosis. Chest. 1996;109(suppl):22S-26S.
29. Husgafvel-Pursiainen K, Kannio A, Oksa P. Mutations, tissue accumulations and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure. Environ Mol Mutagen. 1997;30:224-230.